Medicine composition for treating hepatic disease

A composition and drug technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of inability to achieve lifelong immunity, infection, liver damage, etc.

Inactive Publication Date: 2007-08-15
广州瑞济生物技术有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hepatitis B is the main liver disease currently plaguing our country. It has a high incidence in my country and is rapidly expanding. Although it can be effectively prevented through vaccination, it is difficult to cure infected patients, and vaccination cannot achieve lifelong immunity. , can still infect when the anti

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Mix 300 g of total salvianolic acids of Danshen extract, 300 g of total curcuminoids of turmeric extract, and 50 g of microcrystalline cellulose, granulate with starch slurry, press 1000 tablets, one tablet each time, twice a day.

Embodiment 2

[0017] Mix 300g of total salvianolic acids of salvia miltiorrhiza extract, 150g of total curcuminoids of turmeric extract, 50g of lactose, and 2g of Tween-80, and directly press into 1000 tablets, one tablet each time, twice a day.

Embodiment 3

[0019] Salvia miltiorrhiza extract total salvianolic acids 300g, turmeric extract total curcuminoids 600g, microcrystalline cellulose 50g, mix thoroughly, granulate with starch slurry, pack 2000 capsules of size 0, two capsules each time, twice a day .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese medicinal composition for treating hepatic diseases, which is prepared from effective compositions extracted from red sage root and curcuma longa, wherein wherein the weight ratio of the red sage root effective composition and curcuma longa effective composition is 1:0.5-1:2. The medicinal composition can effectively treating fatty liver, liver fibrosis and hepatocyte necrosis.

Description

technical field [0001] The invention relates to a pharmaceutical composition, especially a composition containing active ingredients extracted from salvia miltiorrhiza and curcuma longa. Background technique [0002] Fatty liver, acute and chronic liver injury are frequently-occurring diseases in clinical practice, especially changes in diet structure and irregular life patterns can easily lead to the occurrence of this disease. Hepatitis B is the main liver disease currently plaguing our country. It has a high incidence in my country and is rapidly expanding. Although it can be effectively prevented through vaccination, it is difficult to cure infected patients, and vaccination cannot achieve lifelong immunity. , can still be infected when the antibody height is reduced. At present, in areas with a high incidence of hepatitis B, more than 10% of the population is infected with hepatitis B virus, and some of them have developed into hepatitis B. Both fatty liver and hepatiti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61K31/343A61P1/16A61K31/122
Inventor 关世侠
Owner 广州瑞济生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap